Success Metrics

Clinical Success Rate
95.0%

Based on 19 completed trials

Completion Rate
95%(19/20)
Active Trials
4(15%)
Results Posted
26%(5 trials)
Terminated
1(4%)

Phase Distribution

Ph not_applicable
2
8%
Ph phase_4
6
23%
Ph phase_2
10
38%
Ph phase_1
2
8%
Ph phase_3
4
15%

Phase Distribution

2

Early Stage

10

Mid Stage

10

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
2(8.3%)
Phase 2Efficacy & side effects
10(41.7%)
Phase 3Large-scale testing
4(16.7%)
Phase 4Post-market surveillance
6(25.0%)
N/ANon-phased studies
2(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.0%

19 of 20 finished

Non-Completion Rate

5.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

26

all time

Status Distribution
Active(4)
Completed(19)
Terminated(1)
Other(2)

Detailed Status

Completed19
Recruiting3
unknown2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
4
Success Rate
95.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (8.3%)
Phase 210 (41.7%)
Phase 34 (16.7%)
Phase 46 (25.0%)
N/A2 (8.3%)

Trials by Status

unknown28%
completed1973%
recruiting312%
active_not_recruiting14%
terminated14%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT03576001Phase 2

Multimodality Intervention for Function and Metabolism in SCI

Completed
NCT05964920Phase 2

Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone?

Completed
NCT05081193Phase 2

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Completed
NCT06188767Not Applicable

Testosterone-induced Muscle Memory and Underlying Mechanisms

Recruiting
NCT03721497Phase 4

Testosterone in Bariatric Patients

Active Not Recruiting
NCT02514629Phase 3

Testosterone, Metformin, or Both, for Hypogonadism in Obese Males

Completed
NCT06489457Phase 3

The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity

Completed
NCT03851627Phase 4

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism

Recruiting
NCT05541172

Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism

Recruiting
NCT04120363Phase 4

Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations

Completed
NCT00911586Phase 2

Pharmacokinetic Study to Determine Time to Steady-state

Completed
NCT04545450Phase 3

Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen

Completed
NCT04134130Not Applicable

The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer

Completed
NCT02966652Phase 1

Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

Completed
NCT00239590Phase 2

Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD)

Completed
NCT03973840Phase 1

Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes

Completed
NCT03792321Phase 4

Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)

Completed
NCT02697188Phase 2

Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men

Completed
NCT01206270Phase 2

Androgen for Leydig Cell Proliferation

Completed
NCT01813201Phase 4

Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26